20 research outputs found
Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes
Recommended from our members
Validation of an Automated Symptom-Based Triage Tool in Ophthalmology.
OBJECTIVES: Acute care ophthalmic clinics often suffer from inefficient triage, leading to suboptimal patient access and resource utilization. This study reports the preliminary results of a novel, symptom-based, patient-directed, online triage tool developed to address the most common acute ophthalmic diagnoses and associated presenting symptoms. METHODS: A retrospective chart review of patients who presented to a tertiary academic medical centers urgent eye clinic after being referred for an urgent, semi-urgent, or nonurgent visit by the ophthalmic triage tool between January 1, 2021 and January 1, 2022 was performed. Concordance between triage category and severity of diagnosis on the subsequent clinic visit was assessed. RESULTS: The online triage tool was utilized 1,370 and 95 times, by the call center administrators (phone triage group) and patients directly (web triage group), respectively. Of all patients triaged with the tool, 8.50% were deemed urgent, 59.2% semi-urgent, and 32.3% nonurgent. At the subsequent clinic visit, the history of present illness had significant agreement with symptoms reported to the triage tool (99.3% agreement, weighted kappa = 0.980, p < 0.001). The triage algorithm also had significant agreement with the severity of the physician diagnosis (97.0% agreement, weighted kappa = 0.912, p < 0.001). Zero patients were found to have a diagnosis on exam that should have corresponded to a higher urgency level on the triage tool. CONCLUSION: The automated ophthalmic triage algorithm was able to safely and effectively triage patients based on symptoms. Future work should focus on the utility of this tool to reduce nonurgent patient load in urgent clinical settings and to improve access for patients who require urgent medical care
Basic 2-year cohort demographics and office visit data.
<p>Basic 2-year cohort demographics and office visit data.</p
2-year cohort data on treatment types and frequencies.
<p>2-year cohort data on treatment types and frequencies.</p
Flow chart for inclusion/exclusion criteria for each of the final cohorts.
<p>*Diagnoses included proliferative retinopathies, sickle cell disease, vein occlusions, pathologic myopia, retinoschisis, age-related macular degeneration, cystoid macular edema, all uveitides, glaucoma and intraocular surgery within 90 days of index date. **Diagnoses included proliferative retinopathies, sickle cell disease, vein occlusions, pathologic myopia, retinoschisis, age-related macular degeneration, cystoid macular edema, all uveitides, and glaucoma.</p
Data on ancillary study types and frequencies in the 2-year cohorts.
<p>Data on ancillary study types and frequencies in the 2-year cohorts.</p
Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort
1-year cohort data on office visits, treatment types and frequencies.
<p>1-year cohort data on office visits, treatment types and frequencies.</p
ICD-9, CPT and Drug codes used in this study.
<p>ICD-9, CPT and Drug codes used in this study.</p